<![CDATA[Sequencing ADCs and Managing Ocular Toxicities in Breast Cancer Populations]]>

Research on AI Models for Predicting Breast Cancer Treatment Effectiveness to Guide Her-2 Targeted ADC Therapy

Conditions : Breast Cancer Sponsors : Zhejiang Cancer Hospital Not yet recruiting

Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM

Conditions : Transthyretin Amyloid Cardiomyopathy Sponsors : AstraZeneca Not yet recruiting

Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy

Methylation-based ctDNA monitoring in 57 patients closely reflects outcomes in ER+, HER2- metastatic breast cancer during CDK4/6 inhibitor t

<![CDATA[AI Test Predicts Breast Cancer Recurrence Using Standard Pathology Slides]]>

<![CDATA[Targeting Aldosterone at Its Source: The Arrival of Baxdrostat for Resistant Hypertension]]>

<![CDATA[From Observation to Treatment: The Role of Caregivers and Overcoming VMAT2 Inhibitor Complexities]]>